Vevzuo 120 mg/1.7 ml (70 mg/ml)

Vevzuo 120 mg/1.7 ml (70 mg/ml) is a medicine authorised by Swissmedic under authorisation number 70142. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 November 2025 and the authorisation is limited until 17 November 2030. ATC code M05BX04 places the medicine in the group Drugs for treatment of bone diseases.

  • Dispensing category A
  • Authorisation number 70142
  • ATC M05BX04
  • Biotechnological medicines
Authorisation data
Authorisation number70142
NameVevzuo 120 mg/1.7 ml (70 mg/ml)
Full nameVevzuo 120 mg/1.7 ml (70 mg/ml), Injektionslösung
Authorisation holderMedius AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeM05BX04
First authorisation18 November 2025
Authorisation validity17 November 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Vevzuo 120 mg/1.7 ml (70 mg/ml), InjektionslösungA18 November 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)M05BX0407.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Vevzuo 120 mg/1.7 ml (70 mg/ml) authorised in Switzerland?

Yes. Vevzuo 120 mg/1.7 ml (70 mg/ml) is authorised by Swissmedic under authorisation number 70142, data as of 01 September 2026. The authorisation is limited until 17 November 2030.

Which dispensing category does Vevzuo 120 mg/1.7 ml (70 mg/ml) have?

Vevzuo 120 mg/1.7 ml (70 mg/ml) is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Vevzuo 120 mg/1.7 ml (70 mg/ml)?

The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com